Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sunscreen TEA Advocates Want Help Scaling FDA’s ‘High Bar’ For OTC Monographs

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA explains its “high bar” for GRASE for sunscreen TEAs during a public meeting on implementation of the Sunscreen Innovation Act. Industry and advocacy groups express concern that impediments to meeting OTC monograph safety standards will squelch sunscreen ingredient innovation.

You may also be interested in...



Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.

FDA Gets Message In Congress' First Cannabis Policy Hearing: Deliver CBD Regulation

During first-ever congressional hearing on federal policies for lawful use of cannabis, House Energy and Commerce Health Subcommittee Chairwoman Anna Eschoo says with $2m appropriated to develop a regulation on CBD’s use in non-drug products during, FDA should deliver.

Vous Vitamin Adds Pregnancy Products To Line Formulated On Customers’ Needs

Vous Vitamin rolls out a pre- and post-natal multivitamin line that factors in diet, lifestyle and pre-pregnancy health. Founders are doctors who say their personalized multivitamins differ from most other customized vitamin lines by delivering nutrition in two pills.

Topics

Related Companies

UsernamePublicRestriction

Register

PS078148

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel